CRSP News and Press, CRISPR Therapeutics AG From 02/21/24

2024-02-21 18:04:03 ET CRISPR Therapeutics AG (CRSP) Citi 2024 Virtual Oncology Leadership Summit Conference February 21, 2024, 01:00 PM ET Company Participants Samarth Kulkarni - Chairman and Chief Executive Officer Conference Call Participants Yigal Nochomo...

2024-02-21 08:48:22 ET More on CRISPR Therapeutics Crispr Therapeutics: Investors Bet Against Casgevy Uptake Biotech And Pharma Diversification Pays Off Vertex And Crispr: Second Casgevy Approval Pushes Revenue Potential Into Multi-Billion Dollar Range Is Cri...

2024-02-21 07:44:28 ET More on CRISPR Therapeutics Crispr Therapeutics: Investors Bet Against Casgevy Uptake Biotech And Pharma Diversification Pays Off Vertex And Crispr: Second Casgevy Approval Pushes Revenue Potential Into Multi-Billion Dollar Range Is Cri...

— CASGEVY™ approved in the U.S., European Union, Great Britain, the Kingdom of Saudi Arabia and Bahrain — — Clinical trials ongoing for next generation CAR T product candidates, CTX112™ and CTX131™ targeting CD...

Kajima Corporation ADR (KAJMY) is expected to report for quarter end 2023-12-31 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 BrewBilt MFG Inc (BBRW) is expected to report for Q4 2023 Correlate Energy Corp. (CIPI) is expected to report for Q4 2023 Hyzon Motors Inc. (...

2024-02-20 05:02:00 ET Cathie Wood's success is based on two main things: finding innovators and betting on them for the long term. The founder and chief executive officer of Ark Invest goes for innovators in all areas, from information technology to healthcare, and this helped her flagship...

2024-02-19 08:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-19 01:45:00 ET Companies in the biotech industry are often capable of delivering explosive returns, especially those with a knack for innovation and breaking new ground. That describes CRISPR Therapeutics (NASDAQ: CRSP) pretty well. The company specializes in gene editing an...

2024-02-16 14:19:48 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cathie Wood stocks make headlines for their potential to be at the leading edge of disruptive technologies and generate high returns. Yet, Wood’s flagship ARK Innovation ETF (NY...

2024-02-15 13:01:01 ET More on CRISPR Therapeutics Crispr Therapeutics: Investors Bet Against Casgevy Uptake Biotech And Pharma Diversification Pays Off Vertex And Crispr: Second Casgevy Approval Pushes Revenue Potential Into Multi-Billion Dollar Range Crispr...